NanoString Technologies to Be Acquired by Bruker Corporation

SEATTLE–(BUSINESS WIRE)–NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities. Following the closing, NanoString’s business operations will no longer
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks